Medication info
Rosuvastatin Calcium and Ezetimibe Tablets, 10/10 mg

Rosuvastatin Calcium and Ezetimibe Tablets, 10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
This medication is a pink, oval-shaped film-coated tablet.
Packaging
30 tablets/box [10 tablets/PTP (Alu-Alu) x 3]
Approval status
Active

MFDS item code 202004137 · Approved 2020.05.29 · Insurance code 646005140

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medication is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medication or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; the dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol.
View approved original text

This medication helps lower elevated total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and increases good cholesterol, HDL cholesterol. It is primarily used in patients at high risk of atherosclerotic vascular diseases due to hypercholesterolemia and should be used in conjunction with dietary measures. It is also important to identify other causes of dyslipidemia, such as diabetes and hypothyroidism, before prescribing this medication and to treat them if necessary. During treatment, total cholesterol, LDL, HDL, and triglyceride levels should be regularly monitored, especially in high-risk situations. This medication is used when dietary control and other non-pharmacological therapies are inadequate and reduces the risk of cardiovascular diseases while improving blood lipid levels.

How to take

Adult dose

This medication is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medication or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; the dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication has been reported to cause a rare side effect known as rhabdomyolysis, which can lead to severe muscle damage. Therefore, if sudden muscle pain, weakness, or muscle cramps occur, consult a doctor immediately. Especially in cases of severe infection, hypotension, major surgery or trauma, or serious metabolic disorders where the risk of muscle damage is high, it may be necessary to temporarily discontinue or stop taking this medication. Patients with an allergy to any component of this medication, active liver disease, unexplained increases in liver enzymes, muscle disorders, severe kidney dysfunction, or women who are pregnant or may become pregnant or are breastfeeding should not take this medication. Furthermore, patients with moderate to severe renal impairment, hypothyroidism, a family history of muscle diseases, alcohol addiction, or those taking specific medications should be cautioned against high doses of this medication. This medication contains lactose, so patients with lactose intolerance or certain genetically inherited metabolic disorders should not take it. Patients with a history of alcohol addiction or liver disease, moderate to severe liver dysfunction, elderly patients, and those with a history of muscle disorders should be closely monitored when taking this medication. This medication may affect liver function, so regular liver function tests should be performed before and during treatment, and if symptoms of liver damage occur, usage should be discontinued immediately. During treatment with this medication, it is important to check for muscle damage through blood tests, and if muscle pain is severe or CPK levels are more than five times the upper limit of normal, the medication should be stopped. This medication may interact with other drugs, so patients taking other medications must inform their doctor or pharmacist, and caution is especially needed when used in combination with blood-thinning medications, certain antibiotics, antifungals, immunosuppressants, and fibrate medications. Women who are pregnant or planning to become pregnant should not take this medication, and during treatment, appropriate contraceptive methods should be used. Safety in children and adolescents has not been adequately established, so it is not recommended for this age group. Elderly patients are also at increased risk of myopathy, so caution is needed during use. In the case of an overdose, since there is no specific antidote, appropriate treatment and monitoring should be provided based on symptoms. This medication should be kept out of reach of children and should preferably not be transferred to another container.

Side effects

nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, increased blood bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, somnolence, neurodegenerative disorder, positional vertigo, migraine, diabetes, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue inflammation, hepatic steatosis, liver dysfunction, hepatic toxicity, acute hepatitis, toxic hepatitis, elevated gamma-glutamyl transferase, increased blood cholesterol, elevated alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid droop, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, asthenia, diabetes, headache, dizziness, constipation, nausea, abdominal pain, diarrhea, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, myalgia, joint pain, elevated CK, asthenia, chest pain, chest discomfort, generalized edema, diabetic neuropathy, tremor, epigastric pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disorder, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival congestion, renal failure, abnormal liver function, increased blood creatinine, elevated blood pressure, increased blood urea, elevated CPK, abnormal liver function tests, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, cholelithiasis, cholecystitis, cognitive decline, forgetfulness, amnesia, memory impairment, confusion, myasthenia gravis, ocular myasthenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The storage temperature should be kept at room temperature between 1 and 30 degrees Celsius. This will help maintain the medication's effectiveness and ensure safe use.

Appearance and packaging

Appearance

This medication is a pink, oval-shaped film-coated tablet.

Package unit

30 tablets/box [10 tablets/PTP (Alu-Alu) x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.